Novo Nordisk’s blockbuster GLP-1 diabetes drug Ozempic led to improvements in some measures of alcohol use disorder in a ...
A paper published Wednesday offers the strongest evidence yet that this is more than just anecdote, or a placebo effect: It ...
A small study confirms observations what users have observed: the medications reduce their cravings for alcohol.
A new study adds to a growing body of evidence that semaglutide has benefits other than weight loss or controlling diabetes.